{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:24:01Z","timestamp":1790965441828,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Key R&D Program of China","award":["2016YFC1301100"],"award-info":[{"award-number":["2016YFC1301100"]}]},{"name":"Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, Heilongjiang Province, China","award":["KF201811"],"award-info":[{"award-number":["KF201811"]}]},{"name":"Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, Heilongjiang Province, China","award":["KF201916"],"award-info":[{"award-number":["KF201916"]}]},{"name":"General Undergraduate Colleges and Universities Young Innovative Talents Training Plan, Heilongjiang Province, China","award":["UNPYSCT-2018075"],"award-info":[{"award-number":["UNPYSCT-2018075"]}]},{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LQ21H020006"],"award-info":[{"award-number":["LQ21H020006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s10557-020-07121-7","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T07:03:15Z","timestamp":1609743795000},"page":"915-925","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Methotrexate Therapy Promotes Cell Coverage and Stability in in-Stent Neointima"],"prefix":"10.1007","volume":"35","author":[{"given":"Xianglan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoxi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guosheng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maomao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingbo","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2045-8567","authenticated-orcid":false,"given":"Bo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,4]]},"reference":[{"key":"7121_CR1","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jacc.2007.10.002","volume":"51","author":"SB King 3rd","year":"2008","unstructured":"King SB 3rd., Smith SC Jr, Hirshfeld JW Jr, et al. 2007 focused update of the ACC\/AHA\/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2008;51:172\u2013209.","journal-title":"J Am Coll Cardiol."},{"key":"7121_CR2","first-page":"e6","volume":"127","author":"AS Go","year":"2013","unstructured":"Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2013;127:e6\u2013245.","journal-title":"Circulation"},{"key":"7121_CR3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jacc.2007.03.031","volume":"50","author":"F Ribichini","year":"2007","unstructured":"Ribichini F, Joner M, Ferrero V, et al. Effects of oral prednisone after stenting in a rabbit model of established atherosclerosis. J Am Coll Cardiol. 2007;50:176\u201385.","journal-title":"J Am Coll Cardiol."},{"key":"7121_CR4","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1136\/hrt.2010.194381","volume":"96","author":"J Hou","year":"2010","unstructured":"Hou J, Qi H, Zhang M, et al. Development of lipid-rich plaque inside bare metal stent: possible mechanism of late stent thrombosis? An optical coherence tomography study. Heart. 2010;96:1187\u201390.","journal-title":"Heart"},{"key":"7121_CR5","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/ccd.26943","volume":"89","author":"S Hu","year":"2017","unstructured":"Hu S, Wang C, Zhe C, et al. Plaque erosion delays vascular healing after drug eluting stent implantation in patients with acute coronary syndrome: an in vivo optical coherence tomography study. Catheter Cardiovasc Interv. 2017;89:592\u2013600.","journal-title":"Catheter Cardiovasc Interv."},{"key":"7121_CR6","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"GK Hansson","year":"2005","unstructured":"Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685\u201395.","journal-title":"N Engl J Med."},{"key":"7121_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.18433\/J30K5Q","volume":"13","author":"T Tunali-Akbay","year":"2010","unstructured":"Tunali-Akbay T, Sehirli O, Ercan F, Sener G. Resveratrol protects against methotrexate-induced hepatic injury in rats. J Pharm Pharm Sci. 2010;13:303\u201310.","journal-title":"J Pharm Pharm Sci."},{"key":"7121_CR8","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1093\/eurheartj\/ehu203","volume":"35","author":"PM Ridker","year":"2014","unstructured":"Ridker PM, Luscher TF. Anti-inflammatory therapies for cardiovascular disease. Eur Heart J. 2014;35:1782\u201391.","journal-title":"Eur Heart J."},{"key":"7121_CR9","doi-asserted-by":"publisher","first-page":"33657","DOI":"10.1038\/srep33657","volume":"6","author":"R Zhang","year":"2016","unstructured":"Zhang R, Chen S, Zhang H, et al. Effects of methotrexate in a rabbit model of in-stent neoatherosclerosis: an optical coherence tomography study. Sci Rep. 2016;6:33657.","journal-title":"Sci Rep."},{"key":"7121_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1136\/heartjnl-2015-308634","volume":"102","author":"MA Sintek","year":"2016","unstructured":"Sintek MA, Sparrow CT, Mikuls TR, et al. Repeat revascularisation outcomes after percutaneous coronary intervention in patients with rheumatoid arthritis. Heart. 2016;102:363\u20139.","journal-title":"Heart"},{"key":"7121_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.14740\/cr468w","volume":"7","author":"V Gouveia","year":"2016","unstructured":"Gouveia V, Oliveira DC, Tenorio E, Brito N, Sarinho E. Percutaneous coronary intervention: safety of methotrexate and its possible benefits on restenosis after bare-metal stent deployment. Cardiol Res. 2016;7:104\u20139.","journal-title":"Cardiol Res."},{"key":"7121_CR12","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1007\/s10554-012-0031-7","volume":"28","author":"J Hou","year":"2012","unstructured":"Hou J, Jia H, Liu H, et al. Neointimal tissue characteristics following sirolimus-eluting stent implantation: OCT quantitative tissue property analysis. Int J Cardiovasc Imaging. 2012;28:1879\u201386.","journal-title":"Int J Cardiovasc Imaging"},{"key":"7121_CR13","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.jcmg.2012.01.024","volume":"5","author":"JS Kim","year":"2012","unstructured":"Kim JS, Hong MK, Shin DH, et al. Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT. JACC Cardiovasc Imaging. 2012;5:1147\u201355.","journal-title":"JACC Cardiovasc Imaging"},{"key":"7121_CR14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0021-9150(01)00738-9","volume":"162","author":"S Inoue","year":"2002","unstructured":"Inoue S, Koyama H, Miyata T, Shigematsu H. Cell replication induces in-stent lesion growth in rabbit carotid artery with preexisting intimal hyperplasia. Atherosclerosis. 2002;162:345\u201353.","journal-title":"Atherosclerosis"},{"key":"7121_CR15","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1136\/annrheumdis-2015-208267","volume":"75","author":"PG Conaghan","year":"2016","unstructured":"Conaghan PG, Ostergaard M, Bowes MA, et al. Comparing the effects of tofacitinib, methotrexate and the combination, on bone marrow oedema, synovitis and bone erosion in methotrexate-naive, early active rheumatoid arthritis: results of an exploratory randomised MRI study incorporating semiquantitative and quantitative techniques. Ann Rheum Dis. 2016;75:1024\u201333.","journal-title":"Ann Rheum Dis."},{"key":"7121_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1136\/hrt.2006.112482","volume":"94","author":"F Prati","year":"2008","unstructured":"Prati F, Zimarino M, Stabile E, et al. Does optical coherence tomography identify arterial healing after stenting? An in vivo comparison with histology, in a rabbit carotid model. Heart. 2008;94:217\u201321.","journal-title":"Heart"},{"key":"7121_CR17","doi-asserted-by":"publisher","first-page":"121867","DOI":"10.1155\/2012\/121867","volume":"2012","author":"J Tian","year":"2012","unstructured":"Tian J, Hu S, Sun Y, et al. A novel model of atherosclerosis in rabbits using injury to arterial walls induced by ferric chloride as evaluated by optical coherence tomography as well as intravascular ultrasound and histology. J Biomed Biotechnol. 2012;2012:121867.","journal-title":"J Biomed Biotechnol."},{"key":"7121_CR18","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1161\/CIRCULATIONAHA.110.988436","volume":"123","author":"SJ Kang","year":"2011","unstructured":"Kang SJ, Mintz GS, Akasaka T, et al. Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation. Circulation. 2011;123:2954\u201363.","journal-title":"Circulation."},{"key":"7121_CR19","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.jacc.2011.01.011","volume":"57","author":"G Nakazawa","year":"2011","unstructured":"Nakazawa G, Otsuka F, Nakano M, et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol. 2011;57:1314\u201322.","journal-title":"J Am Coll Cardiol."},{"key":"7121_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.amjcard.2012.08.037","volume":"111","author":"S Kim","year":"2013","unstructured":"Kim S, Kim JS, Shin DH, et al. Comparison of early strut coverage between zotarolimus- and everolimus-eluting stents using optical coherence tomography. Am J Cardiol. 2013;111:1\u20135.","journal-title":"Am J Cardiol."},{"key":"7121_CR21","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0735-1097(97)00450-6","volume":"31","author":"R Kornowski","year":"1998","unstructured":"Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol. 1998;31:224\u201330.","journal-title":"J Am Coll Cardiol."},{"key":"7121_CR22","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.biomaterials.2009.09.079","volume":"31","author":"SL Chin-Quee","year":"2010","unstructured":"Chin-Quee SL, Hsu SH, Nguyen-Ehrenreich KL, et al. Endothelial cell recovery, acute thrombogenicity, and monocyte adhesion and activation on fluorinated copolymer and phosphorylcholine polymer stent coatings. Biomaterials. 2010;31:648\u201357.","journal-title":"Biomaterials"},{"key":"7121_CR23","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jacc.2008.04.030","volume":"52","author":"M Joner","year":"2008","unstructured":"Joner M, Nakazawa G, Finn AV, et al. Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol. 2008;52:333\u201342.","journal-title":"J Am Coll Cardiol."},{"key":"7121_CR24","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1161\/CIRCINTERVENTIONS.114.001522","volume":"7","author":"T Miyake","year":"2014","unstructured":"Miyake T, Ihara S, Miyake T, et al. Prevention of neointimal formation after angioplasty using nuclear factor-\u03baB decoy oligodeoxynucleotide-coated balloon catheter in rabbit model. Circ Cardiovasc Interv. 2014;7:787\u201396.","journal-title":"Circ Cardiovasc Interv."},{"key":"7121_CR25","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1136\/annrheumdis-2014-206305","volume":"75","author":"CC Thornton","year":"2016","unstructured":"Thornton CC, Al-Rashed F, Calay D, et al. Methotrexate-mediated activation of an AMPK-CREB-dependent pathway: a novel mechanism for vascular protection in chronic systemic inflammation. Ann Rheum Dis. 2016;75:439\u201348.","journal-title":"Ann Rheum Dis."},{"key":"7121_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10557-014-6566-1","volume":"29","author":"AC Leite Jr","year":"2015","unstructured":"Leite AC Jr, Solano TV, Tavares ER, Maranhao RC. Use of combined chemotherapy with etoposide and methotrexate, both associated to lipid nanoemulsions for atherosclerosis treatment in cholesterol-fed rabbits. Cardiovasc Drugs Ther. 2015;29:15\u201322.","journal-title":"Cardiovasc Drugs Ther."},{"key":"7121_CR27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fcvm.2019.00016","volume":"6","author":"AW Aday","year":"2019","unstructured":"Aday AW, Ridker PM. Targeting residual inflammatory risk: a shifting paradigm for atherosclerotic disease. Front Cardiovasc Med. 2019;6:16.","journal-title":"Front Cardiovasc Med."},{"key":"7121_CR28","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1093\/eurheartj\/ehy633","volume":"39","author":"DN Kalkman","year":"2018","unstructured":"Kalkman DN, Aquino M, Claessen BE, et al. Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions. Eur Heart J. 2018;39:4101\u20138.","journal-title":"Eur Heart J."},{"key":"7121_CR29","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.amjcard.2011.06.054","volume":"108","author":"R Micha","year":"2011","unstructured":"Micha R, Imamura F, Wyler von Ballmoos M, et al. Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease. Am J Cardiol. 2011;108:1362\u201370.","journal-title":"Am J Cardiol."},{"key":"7121_CR30","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","volume":"74","author":"C Roubille","year":"2015","unstructured":"Roubille C, Richer V, Starnino T, et al. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74:480\u20139.","journal-title":"Ann Rheum Dis."},{"key":"7121_CR31","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1177\/1074248417699884","volume":"22","author":"DM Moreira","year":"2017","unstructured":"Moreira DM, Lueneberg ME, da Silva RL, Fattah T, Gottschall CAM. Methotrexate therapy in ST-segment elevation myocardial infarctions: a randomized double-blind, placebo-controlled trial (TETHYS Trial). J Cardiovasc Pharmacol Ther. 2017;22:538\u201345.","journal-title":"J Cardiovasc Pharmacol Ther."},{"key":"7121_CR32","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1097\/00005344-200404000-00013","volume":"43","author":"H Asanuma","year":"2004","unstructured":"Asanuma H, Sanada S, Ogai A, et al. Methotrexate and MX-68, a new derivative of methotrexate, limit infarct size via adenosine-dependent mechanisms in canine hearts. J Cardiovasc Pharmacol. 2004;43:574\u20139.","journal-title":"J Cardiovasc Pharmacol."},{"key":"7121_CR33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1161\/01.ATV.0000191635.00744.b6","volume":"26","author":"X Yang","year":"2006","unstructured":"Yang X, Thomas DP, Zhang X, et al. Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation. Arterioscler Thromb Vasc Biol. 2006;26:85\u201390.","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"7121_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1161\/CIRCULATIONAHA.113.001790","volume":"129","author":"F Otsuka","year":"2014","unstructured":"Otsuka F, Vorpahl M, Nakano M, et al. Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans. Circulation. 2014;129:211\u201323.","journal-title":"Circulation"},{"key":"7121_CR35","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.107.693739","volume":"115","author":"AV Finn","year":"2007","unstructured":"Finn AV, Joner M, Nakazawa G, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007;115:2435\u201341.","journal-title":"Circulation"},{"key":"7121_CR36","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/hrt.2002.008169","volume":"90","author":"Y Huang","year":"2004","unstructured":"Huang Y, Salu K, Liu X, et al. Methotrexate loaded SAE coated coronary stents reduce neointimal hyperplasia in a porcine coronary model. Heart. 2004;90:195\u20139.","journal-title":"Heart"},{"key":"7121_CR37","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/cvr\/cvt115","volume":"99","author":"C Chaabane","year":"2013","unstructured":"Chaabane C, Otsuka F, Virmani R, Bochaton-Piallat ML. Biological responses in stented arteries. Cardiovasc Res. 2013;99:353\u201363.","journal-title":"Cardiovasc Res."},{"key":"7121_CR38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/rheumatology\/kem279","volume":"47","author":"JA Wessels","year":"2008","unstructured":"Wessels JA, Huizinga TW, Guchelaar HJ. Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis. Rheumatology (Oxford). 2008;47:249\u201355.","journal-title":"Rheumatology (Oxford)"},{"key":"7121_CR39","first-page":"4","volume":"18","author":"AC Holliday","year":"2013","unstructured":"Holliday AC, Moody MN, Berlingeri-Ramos A. Methotrexate: role of treatment in skin disease. Skin Ther Lett. 2013;18:4\u20139.","journal-title":"Skin Ther Lett."},{"key":"7121_CR40","doi-asserted-by":"publisher","first-page":"15019","DOI":"10.1038\/ncomms15019","volume":"8","author":"C Corciulo","year":"2017","unstructured":"Corciulo C, Lendhey M, Wilder T, et al. Endogenous adenosine maintains cartilage homeostasis and exogenous adenosine inhibits osteoarthritis progression. Nat Commun. 2017;8:15019.","journal-title":"Nat Commun."},{"key":"7121_CR41","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.2174\/092986707781368423","volume":"14","author":"AM Martelli","year":"2007","unstructured":"Martelli AM, Tazzari PL, Evangelisti C, et al. Targeting the phosphatidylinositol 3-kinase\/Akt\/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside. Curr Med Chem. 2007;14:2009\u201323.","journal-title":"Curr Med Chem."},{"key":"7121_CR42","first-page":"28","volume":"35","author":"S Shishodia","year":"2002","unstructured":"Shishodia S, Aggarwal BB. Nuclear factor-kappaB activation: a question of life or death. J Biochem Mol Biol. 2002;35:28\u201340.","journal-title":"J Biochem Mol Biol."},{"key":"7121_CR43","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ccr.2004.09.003","volume":"6","author":"BB Aggarwal","year":"2004","unstructured":"Aggarwal BB. Nuclear factor-kappaB: the enemy within. Cancer Cell. 2004;6:203\u20138.","journal-title":"Cancer Cell."},{"key":"7121_CR44","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.jcmg.2014.05.004","volume":"7","author":"JS Kim","year":"2014","unstructured":"Kim JS, Lee JH, Shin DH, et al. Long-term outcomes of neointimal hyperplasia without neoatherosclerosis after drug-eluting stent implantation. JACC Cardiovasc Imaging. 2014;7:788\u201395.","journal-title":"JACC Cardiovasc Imaging."}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-020-07121-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-020-07121-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-020-07121-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T06:12:59Z","timestamp":1632118379000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-020-07121-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,4]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["7121"],"URL":"https:\/\/doi.org\/10.1007\/s10557-020-07121-7","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,4]]},"assertion":[{"value":"4 December 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Hospital Scientific Affairs Committee on Animal Research and Ethics approved the study protocol, and the methods were performed in accordance with the ARRIVE guidelines. All applicable international, national and\/or institutional guidelines for the care and use of animals were followed. All rabbits were obtained from the animal centre of Harbin Medical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This article does not contain any studies involving human participants performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}